Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine

References

• Abrams, D. I., Hilton, J. F., Leiser, R. J., Shade, S. B., Elbeik, T. A., Aweeka, F. T., Benowitz, N. L., Bredt, B. M., Kosel, B., Aberg, J. A., Deeks, S. G., Mitchell, T. F., Mulligan, K., Bacchetti, P., McCune, J. M., & Schambelan, M. (2003). Short-term effects of cannabinoids in patients with HIV-1 infection: A randomized, placebo-controlled clinical trial. Annals of Internal Medicine, 139(4), 258–266. https://doi.org/10.7326/0003-4819-139-4-200308190-00008
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381. https://doi.org/10.1046/j.1525-1497.2002.10644.x
   PubMed Web of Science ®Google Scholar
• Bonn-Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2014). Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. Journal of Behavioral Medicine, 37(1), 1–10. https://doi.org/10.1007/s10865-012-9458-5
   PubMed Web of Science ®Google Scholar
• Bredt, B. M., Higuera-Alhino, D., Shade, S. B., Hebert, S. J., McCune, J. M., & Abrams, D. I. (2002). Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. Journal of Clinical Pharmacology, 42(S1), 82S–89S. https://doi.org/10.1002/j.1552-4604.2002.tb06007.x
   PubMedGoogle Scholar
• Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen , M., Chan, G., Mattick, R. P., Blyth, F., Shanahan, M., Dobbins, T., Farrell, M., & Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. Lancet Public Health, 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., & Gallant, J. E. (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (London, England), 15(13), 1707–1715. https://doi.org/10.1097/00002030-200109070-00015
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. (2017). Understanding the HIV care continuum. https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf
   Google Scholar
• Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016). Marijuana use and use disorders in adults in the USA, 2002-14: Analysis of annual cross-sectional surveys. The Lancet. Psychiatry, 3(10), 954–964. https://doi.org/10.1016/S2215-0366(16)30208-5
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O. (2017). Project FIRST – financial incentives to reduce substance use and improve treatment. ClinicalTrials.gov.
   Google Scholar
• Damkier, P., Lassen, D., Christensen, M. M. H., Madsen, K. G., Hellfritzsch, M., & Pottegard, A. (2019). Interaction between warfarin and cannabis. Basic & Clinical Pharmacology & Toxicology, 124(1), 28–31. https://doi.org/10.1111/bcpt.13152
   PubMed Web of Science ®Google Scholar
• Dash, S., Balasubramaniam, M., Villalta, F., Dash, C., & Pandhare, J. (2015). Impact of cocaine abuse on HIV pathogenesis. Frontiers in Microbiology, 6, 1111. https://doi.org/10.3389/fmicb.2015.01111
   PubMed Web of Science ®Google Scholar
• de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D. M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndromes, 38(1), 43–46. https://doi.org/10.1097/00126334-200501010-00008
   PubMed Web of Science ®Google Scholar
• D'Souza, G., Matson, P. A., Grady, C. D., Nahvi, S., Merenstein, D., Weber, K. M., Greenblatt, R., Burian, P., & Wilson, T. E. (2012). Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV study (WIHS) cohort, 1994-2010. Journal of Acquired Immune Deficiency Syndromes, 61(5), 618–626. https://doi.org/10.1097/QAI.0b013e318273ab3a
   PubMed Web of Science ®Google Scholar
• Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., Inciardi, J. A., Bowser, B. P., Schilling, R. F., & Holmberg, S. D.(1994). Intersecting epidemics–crack cocaine use and HIV infection among inner-city young adults. Multicenter crack cocaine and HIV Infection Study Team. New England Journal of Medicine, 331(21), 1422–1427. https://doi.org/10.1056/nejm199411243312106
   PubMed Web of Science ®Google Scholar
• Fischer, B., Blanken, P., Da Silveira, D., Gallassi, A., Goldner, E. M., Rehm, J., Tyndall, M., & Wood, E. (2015). Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies. The International Journal on Drug Policy, 26(4), 352–363. https://doi.org/10.1016/j.drugpo.2015.01.002
   PubMed Web of Science ®Google Scholar
• Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S., & Bendayan, R. (2004). Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs, 18(4), 215–228. https://doi.org/10.1089/108729104323038892
   PubMed Web of Science ®Google Scholar
• Glenn, M. C., Sohler, N. L., Starrels, J. L., Maradiaga, J., Jost, J. J., Arnsten, J. H., & Cunningham, C. O. (2016). Characteristics of methadone maintenance treatment patients prescribed opioid analgesics. Substance Abuse, 37(3), 387–391. https://doi.org/10.1080/08897077.2015.1135225
   PubMed Web of Science ®Google Scholar
• Harris, G. E., Dupuis, L., Mugford, G. J., Johnston, L., Haase, D., Page, G., Haldane, H., Harris, N., Midodzi, W. K., & Dow, G. (2014). Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. The Canadian Journal Of infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies infectieuses Et De La Microbiologie Medicale / Ammi Canada, 25(1), e1–e7. https://doi.org/10.1155/2014/301713
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., Myers, H. F., & Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. https://doi.org/10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16(2), 199–211. https://doi.org/10.1080/09540120410001641048
   PubMed Web of Science ®Google Scholar
• Lake, S., Kerr, T., Capler, R., Shoveller, J., Montaner, J., & Milloy, M. J. (2017). High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. The International Journal on Drug Policy, 42, 63–70. https://doi.org/10.1016/j.drugpo.2017.02.009
   PubMed Web of Science ®Google Scholar
• Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S. O., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654–659. https://doi.org/10.1111/dar.12275
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16(5), 767–774. https://doi.org/10.1097/00002030-200203290-00012
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Mullen, B. A., McCaul, M. E., Weidle, P. J., Hader, S., & Moore, R. D. (2007). Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care and STDs, 21(8), 564–574. https://doi.org/10.1089/apc.2006.0192
   PubMed Web of Science ®Google Scholar
• Lucas, P., Reiman, A., Earleywine, M., McGowan, S. K., Oleson, M., Coward, M. P., & Thomas, B. (2013). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 21(5), 435–442. https://doi.org/10.3109/16066359.2012.733465
   Web of Science ®Google Scholar
• Lucas, P., Walsh, Z., Crosby, K., Callaway, R., Belle-Isle, L., Kay, R., Capler, R., & Holtzman, S.(2016). Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review, 35(3), 326–333. https://doi.org/10.1111/dar.12323
   PubMed Web of Science ®Google Scholar
• Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14(4), 731–747. https://doi.org/10.1007/s10461-008-9489-7
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9(3), 199–213. https://doi.org/10.1016/0740-5472(92)90062-s
   PubMed Web of Science ®Google Scholar
• Milloy, M. J., Marshall, B., Kerr, T., Richardson, L., Hogg, R., Guillemi, S., Montaner, J. S. G., & Wood, E. (2015). High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug and Alcohol Review, 34(2), 135–140. https://doi.org/10.1111/dar.12223
   PubMed Web of Science ®Google Scholar
• Mimiaga, M. J., Reisner, S. L., Grasso, C., Crane, H. M., Safren, S. A., Kitahata, M. M., Schumacher, J. E., Christopher Mathews, W., & Mayer, K. H. (2013). Substance use among HIV-infected patients engaged in primary care in the United States: Findings from the centers for AIDS research Network of Integrated clinical Systems cohort. American Journal of Public Health, 103(8), 1457–1467. https://doi.org/10.2105/AJPH.2012.301162
   PubMed Web of Science ®Google Scholar
• Monte, A. A., Shelton, S. K., Mills, E., Saben, J., Hopkinson, A., Sonn, B., Devivo, M., Chang, T., Fox, J., Brevik, C., Williamson, K., & Abbott, D. (2019). Acute Illness associated with cannabis use, by route of exposure: An Observational study. Annals of Internal Medicine, 170(8), 531–537. https://doi.org/10.7326/M18-2809
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. (2019). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Retrieved January 10, 2019, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Parker, L. A., Burton, P., Sorge, R. E., Yakiwchuk, C., & Mechoulam, R. (2004). Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl), 175(3), 360–366. https://doi.org/10.1007/s00213-004-1825-7
   PubMed Web of Science ®Google Scholar
• Prud'homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an Intervention for addictive behaviors: A systematic review of the evidence. Substance Abuse, 9, 33–38. https://doi.org/10.4137/SART.S25081
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
   Web of Science ®Google Scholar
• Rasbach, D. A., Desruisseau, A. J., Kipp, A. M., Stinnette, S., Kheshti, A., Shepherd, B. E., Sterling, T. R., Hulgan, T., McGowan, C. C., & Qian, H.-Z. (2013). Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: Use of a rapid screening tool during routine clinic visits. AIDS Care, 25(1), 109–117. https://doi.org/10.1080/09540121.2012.687814
   PubMed Web of Science ®Google Scholar
• Reddon, H., DeBeck, K., Socias, M. E., Dong, H., Wood, E., Montaner, J., Kerr, T., & Milloy, M. J. (2018). Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis. Drug and Alcohol Review, 37(3), 421–428. https://doi.org/10.1111/dar.12667
   PubMed Web of Science ®Google Scholar
• Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., John Gill, M., Justice, A., Kirk, G., Klein, M. B., Todd Korthuis, P., Martin, J., Napravnik, S., Rourke, S. B., Sterling, T. R., Silverberg, M. J., Deeks, S.,  …  for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), e81355. https://doi.org/10.1371/journal.pone.0081355
   PubMed Web of Science ®Google Scholar
• Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders Identification test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption–II. Addiction, 88(6), 791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x
   PubMed Web of Science ®Google Scholar
• Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29(2), 117–127. https://doi.org/10.1023/b:johe.0000016716.99847.9b
   PubMed Web of Science ®Google Scholar
• Slawson, G., Milloy, M. J., Balneaves, L., Simo, A., Guillemi, S., Hogg, R., Montaner, J., Wood, E., & Kerr, T. (2015). High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS and Behavior, 19(1), 120–127. https://doi.org/10.1007/s10461-014-0847-3
   PubMed Web of Science ®Google Scholar
• Socias, M. E., Kerr, T., Wood, E., Dong, H., Lake, S., Hayashi, K., DeBeck, K., Jutras-Aswad, D., Montaner, J., & Milloy, M.-J. (2017). Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addictive Behaviors, 72, 138–143. https://doi.org/10.1016/j.addbeh.2017.04.006
   PubMed Web of Science ®Google Scholar
• Sohler, N. L., Starrels, J. L., Khalid, L., Bachhuber, M. A., Arnsten, J. H., Nahvi, S., Jost, J., & Cunningham, C. O. (2018). Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. Substance Use & Misuse, 53(10), 1602–1607. https://doi.org/10.1080/10826084.2017.1416408
   PubMed Web of Science ®Google Scholar
• Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114(7), 573–580. https://doi.org/10.1016/s0002-9343
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219–2227. https://doi.org/10.1056/NEJMra1402309
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Valerie Curran, H., & Baler, R. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry, 73(3), 292–297. https://doi.org/10.1001/jamapsychiatry.2015.3278
   PubMed Web of Science ®Google Scholar
• Wang, C., Vlahov, D., Galai, N., Bareta, J., Strathdee, S. A., Nelson, K. E., & Sterling, T. R. (2004). Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: Implications for when to initiate therapy. Journal of Infectious Diseases, 190(6), 1046–1054. https://doi.org/10.1086/422848
   PubMed Web of Science ®Google Scholar
• Webber, M. P., Schoenbaum, E. E., Gourevitch, M. N., Buono, D., & Klein, R. S. (1999). A prospective study of HIV disease progression in female and male drug users. AIDS, 13(2), 257–262. https://doi.org/10.1097/00002030-199902040-00014
   PubMed Web of Science ®Google Scholar
• Zolopa, A. R. (2010). The evolution of HIV treatment guidelines: Current state-of-the-art of ART. Antiviral Research, 85(1), 241–244. https://doi.org/10.1016/j.antiviral.2009.10.018
   PubMed Web of Science ®Google Scholar